Promoting and protecting the health and safety of all Idahoans
Español    Idaho.gov    About Us    Contact Us  

Pharmacy and Therapeutics Committee

The Idaho Medicaid Pharmacy and Therapeutics Committee (P&T Committee) is comprised of Idaho health practitioners – physicians, physician assistant, pharmacists – who are committed to providing the right care at the right price. This committee meets four times per year to review clinical evidence. The P&T Committee makes recommendations to the Department of Health and Welfare regarding drug safety and efficacy as well as prior authorization requirements. Cost modeling analysis is done by the department twice per year – following the committee meetings in May and November.

Preferred Drug List (PDL)

General P&T Information

2015 Meeting Dates:

  •     April 24, 2015 
  •     May 22, 2015 
  •     October 16, 2015
  •     November 20, 2015

Updates

  • Effective 4/8/2015: Irritable Bowel Syndrome drug class name has been changed to GI Motility, Chronic to more accurately reflect that these medications (Amitiza, Linzess, Lotrenex) are used to treat chronic constipation as well as irritable bowel syndrome.

Members

Voting Members

  • Perry Brown, M.D. (Board Chairman, Boise, serving since January 2009)
  • Troy Geyman, M.D. (Bonners Ferry, serving since 2012)
  • Jeffrey Johnson, PA (Meridian, serving since 2011)
  • Leigh Morse, M.D. (Hailey, serving since 2012)
  • Kevin Ellis, PharmD (McCall, serving since 2012)
  • David Calley, PharmD (Meridian, serving since 2012)
  • Brian Crownover, M.D. (Meridian, serving since 2015)
  • Stephen Carlson, PharmD (Boise, serving since 2014)

Non-Voting Members

  • Mark Turner, MD (Boise, serving since January 2009)
  • Tamara Eide, PharmD (Medicaid Pharmacy Supervisor)
  • Mark Johnston, RPh (Idaho Board of Pharmacy)